A strong H1 trading update and significant strategic progress should support a further re-rating of the shares. The increased focus and simplification of the model is delivering tangible improvements and confidence is increasing in the value and deliverability of the new product development pipeline. After putting through underlying upgrades in June, we leave our forecasts unchanged for now, but see scope for further upside with continued strong execution.

09 Aug 2017
N+1 Singer - Quantum Pharma - Positive H1 trading update

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Quantum Pharma - Positive H1 trading update
A strong H1 trading update and significant strategic progress should support a further re-rating of the shares. The increased focus and simplification of the model is delivering tangible improvements and confidence is increasing in the value and deliverability of the new product development pipeline. After putting through underlying upgrades in June, we leave our forecasts unchanged for now, but see scope for further upside with continued strong execution.